MS patients to get routine access to beta interferon drug

But MS Society warns guidance limits patient choice Related items fromOnMedica A clinical review of multiple sclerosis New multiple sclerosis drug hailed as a 'landmark' MS patients miss out on specialist support Stem cell transplant shows promise for MS outcomes
Source: OnMedica Latest News - Category: UK Health Source Type: news